102 related articles for article (PubMed ID: 11357249)
1. Mass population screening for colorectal cancer: factors influencing subjects' choice of screening test.
Frew E; Wolstenholme J; Whynes D
J Health Serv Res Policy; 2001 Apr; 6(2):85-91. PubMed ID: 11357249
[TBL] [Abstract][Full Text] [Related]
2. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
[TBL] [Abstract][Full Text] [Related]
3. Eliciting relative preferences for two methods of colorectal cancer screening.
Frew EJ; Wolstenholme JL; Whynes DK
Eur J Cancer Care (Engl); 2005 May; 14(2):124-31. PubMed ID: 15842459
[TBL] [Abstract][Full Text] [Related]
4. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
[TBL] [Abstract][Full Text] [Related]
5. Is the type of test used for mass colorectal cancer screening a determinant of compliance? A cluster-randomized controlled trial comparing fecal occult blood testing with flexible sigmoidoscopy.
Federici A; Marinacci C; Mangia M; Borgia P; Giorgi Rossi P; Guasticchi G
Cancer Detect Prev; 2006; 30(4):347-53. PubMed ID: 16965874
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
7. Willingness-to-pay for colorectal cancer screening.
Frew E; Wolstenholme JL; Whynes DK
Eur J Cancer; 2001 Sep; 37(14):1746-51. PubMed ID: 11549427
[TBL] [Abstract][Full Text] [Related]
8. A comparison of two methods for eliciting contingent valuations of colorectal cancer screening.
Whynes DK; Frew E; Wolstenholme JL
J Health Econ; 2003 Jul; 22(4):555-74. PubMed ID: 12842315
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial).
Denis B; Gendre I; Aman F; Ribstein F; Maurin P; Perrin P
Eur J Cancer; 2009 Dec; 45(18):3282-90. PubMed ID: 19665368
[TBL] [Abstract][Full Text] [Related]
10. Psychiatric morbidity and screening for colorectal cancer.
Parker MA; Robinson MH; Scholefield JH; Hardcastle JD
J Med Screen; 2002; 9(1):7-10. PubMed ID: 11943790
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting compliance with colorectal cancer screening in France: differences between intention to participate and actual participation.
Herbert C; Launoy G; Gignoux M
Eur J Cancer Prev; 1997 Feb; 6(1):44-52. PubMed ID: 9161812
[TBL] [Abstract][Full Text] [Related]
12. Concerns, perceived need and competing priorities: a qualitative exploration of decision-making and non-participation in a population-based flexible sigmoidoscopy screening programme to prevent colorectal cancer.
Hall N; Birt L; Rees CJ; Walter FM; Elliot S; Ritchie M; Weller D; Rubin G
BMJ Open; 2016 Nov; 6(11):e012304. PubMed ID: 27836872
[TBL] [Abstract][Full Text] [Related]
13. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening.
DeBourcy AC; Lichtenberger S; Felton S; Butterfield KT; Ahnen DJ; Denberg TD
J Gen Intern Med; 2008 Feb; 23(2):169-74. PubMed ID: 18157581
[TBL] [Abstract][Full Text] [Related]
14. Limitations of the faecal occult blood test in screening for colorectal cancer.
Delcò F; Sonnenberg A
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
[TBL] [Abstract][Full Text] [Related]
15. Preferences for colorectal cancer screening techniques and intention to attend: a multi-criteria decision analysis.
Hummel JM; Steuten LG; Groothuis-Oudshoorn CJ; Mulder N; Ijzerman MJ
Appl Health Econ Health Policy; 2013 Oct; 11(5):499-507. PubMed ID: 23979875
[TBL] [Abstract][Full Text] [Related]
16. Comparing different strategies for colorectal cancer screening in Italy: predictors of patients' participation.
Senore C; Armaroli P; Silvani M; Andreoni B; Bisanti L; Marai L; Castiglione G; Grazzini G; Taddei S; Gasperoni S; Giuliani O; Malfitana G; Marutti A; Genta G; Segnan N
Am J Gastroenterol; 2010 Jan; 105(1):188-98. PubMed ID: 19826409
[TBL] [Abstract][Full Text] [Related]
17. A case-control study to evaluate efficacy of screening for faecal occult blood.
Lazovich D; Weiss NS; Stevens NG; White E; McKnight B; Wagner EH
J Med Screen; 1995; 2(2):84-9. PubMed ID: 7497161
[TBL] [Abstract][Full Text] [Related]
18. Manipulating perceptions of colorectal cancer threat: implications for screening intentions and behaviors.
Lipkus IM; Green LG; Marcus A
J Health Commun; 2003; 8(3):213-28. PubMed ID: 12857652
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with participation in screening for colorectal cancer with faecal occult blood testing.
Lindholm E; Berglund B; Haglind E; Kewenter J
Scand J Gastroenterol; 1995 Feb; 30(2):171-6. PubMed ID: 7732341
[TBL] [Abstract][Full Text] [Related]
20. Patient preferences for colorectal cancer screening.
Leard LE; Savides TJ; Ganiats TG
J Fam Pract; 1997 Sep; 45(3):211-8. PubMed ID: 9300000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
